A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy.

This study has been terminated.

( This study was stopped early due to slow enrollment. )

Study NCT00350090 Information provided by Ortho Biotech Products, L.P.

First Received: July 7, 2006 Last Updated: May 17, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	March 2004
Estimated Primary Completion Date:	No date given

Publications: